Literature DB >> 16440222

Diffusion MRI findings in phenylketonuria.

R N Sener1.   

Abstract

Two patients with phenylketonuria were studied who were under dietary control since infancy, and who were mentally normal. Diffusion MRI was obtained using a spin-echo, echo-planar sequence with a gradient strength of 30 mT/m at 1.5 T. A trace sequence (TR=5700 ms, and TE=139 ms) was used, acquired in 22 s. Heavily diffusion-weighted (b=1000 mm(2)/s) images, and the apparent diffusion coefficient (ADC) values from automatically generated ADC maps were studied. There were two different patterns in these two patients, restricted and increased diffusion patterns. Restricted diffusion pattern consisted of high-signal on b=1000 s/mm(2) images with low ADC values ranging from 0.46 to 0.57 x 10(-3 )mm2/s. Increased diffusion pattern consisted of normal b=1000 s/mm(2 )images with high ADC values ranging from 1.37 to 1.63 x 10(-3 )mm2/s. It is likely that these values reflected presence of two different histopathological changes in phenylketonuria or reflected different stages of the same disease.

Entities:  

Mesh:

Year:  2003        PMID: 16440222     DOI: 10.1007/s00330-002-1778-3

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  17 in total

1.  An alternative explanation of the origin of the signal in diffusion-weighted MRI.

Authors:  G Branco
Journal:  Neuroradiology       Date:  2000-02       Impact factor: 2.804

2.  Neuro-pathologic observations in phenylketonuria.

Authors:  C M POSER; L VAN BOGAERT
Journal:  Brain       Date:  1959-03       Impact factor: 13.501

3.  The pathological report of a case of phenylpyruvic oligophrenia.

Authors:  J A CORSELLIS
Journal:  J Neurol Neurosurg Psychiatry       Date:  1953-08       Impact factor: 10.154

Review 4.  Disorders of lysosomes, peroxisomes, and mitochondria.

Authors:  B E Kendall
Journal:  AJNR Am J Neuroradiol       Date:  1992 Mar-Apr       Impact factor: 3.825

5.  Neuropathological findings in phenyl-pyruvic oligophrenia (phenyl-ketonuria).

Authors:  E C ALVORD; L D STEVENSON; F S VOGEL; R L ENGLE
Journal:  J Neuropathol Exp Neurol       Date:  1950-07       Impact factor: 3.685

6.  MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders.

Authors:  D Le Bihan; E Breton; D Lallemand; P Grenier; E Cabanis; M Laval-Jeantet
Journal:  Radiology       Date:  1986-11       Impact factor: 11.105

7.  Diffusion-weighted imaging of white matter abnormalities in patients with phenylketonuria.

Authors:  M D Phillips; P McGraw; M J Lowe; V P Mathews; B E Hainline
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

8.  Decreased diffusion in central pontine myelinolysis.

Authors:  S C Cramer; K C Stegbauer; A Schneider; J Mukai; K R Maravilla
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

9.  Phenylketonuria: MR imaging of the brain with clinical correlation.

Authors:  K D Pearsen; A D Gean-Marton; H L Levy; K R Davis
Journal:  Radiology       Date:  1990-11       Impact factor: 11.105

10.  Clinical experience with diffusion-weighted MR in patients with acute stroke.

Authors:  K O Lövblad; H J Laubach; A E Baird; F Curtin; G Schlaug; R R Edelman; S Warach
Journal:  AJNR Am J Neuroradiol       Date:  1998 Jun-Jul       Impact factor: 3.825

View more
  3 in total

1.  Effects of phenylalanine and its metabolites on cytoplasmic free calcium in cortical neurons.

Authors:  Y G Yu; F G Tang; J Pan; X F Gu
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 3.996

2.  Brain MRI diffusion-weighted imaging in patients with classical phenylketonuria.

Authors:  Renzo Manara; Alessandro P Burlina; Valentina Citton; Mario Ermani; Francesco Vespignani; Carla Carollo; Alberto B Burlina
Journal:  Neuroradiology       Date:  2009-08-04       Impact factor: 2.804

3.  Meta-analysis of neuropsychological symptoms of adolescents and adults with PKU.

Authors:  J J Moyle; A M Fox; M Arthur; M Bynevelt; J R Burnett
Journal:  Neuropsychol Rev       Date:  2007-04-05       Impact factor: 7.444

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.